FMS Relative Valuation
FMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FMS is overvalued; if below, it's undervalued.
Historical Valuation
Fresenius Medical Care AG (FMS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 12.25 is considered Undervalued compared with the five-year average of 14.64. The fair price of Fresenius Medical Care AG (FMS) is between 32.17 to 44.40 according to relative valuation methord. Compared to the current price of 27.23 USD , Fresenius Medical Care AG is Undervalued By 15.37%.
Relative Value
Fair Zone
32.17-44.40
Current Price：27.23
15.37%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.95
P/B
Median3y
0.73
Median5y
1.06
12.59
FCF Yield
Median3y
14.45
Median5y
13.64
Competitors Valuation Multiple
The average P/S ratio for FMS's competitors is 1.87, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS) exhibits a P/S ratio of 0.69, which is -63.31% above the industry average. Given its robust revenue growth of 0.04%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Fresenius Medical Care AG (FMS) currently overvalued or undervalued?
What is Fresenius Medical Care AG (FMS) fair value?
How does FMS's valuation metrics compare to the industry average?
What is the current P/B ratio for Fresenius Medical Care AG (FMS) as of Jul 18 2025?
What is the current FCF Yield for Fresenius Medical Care AG (FMS) as of Jul 18 2025?
What is the current Forward P/E ratio for Fresenius Medical Care AG (FMS) as of Jul 18 2025?